KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Guardant Health (GH) Operating Income: 2017-2025

Historic Operating Income for Guardant Health (GH) over the last 8 years, with Sep 2025 value amounting to -$99.0 million.

  • Guardant Health's Operating Income rose 15.63% to -$99.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$442.4 million, marking a year-over-year increase of 14.12%. This contributed to the annual value of -$443.6 million for FY2024, which is 21.45% up from last year.
  • Latest data reveals that Guardant Health reported Operating Income of -$99.0 million as of Q3 2025, which was up 6.98% from -$106.4 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Operating Income registered a high of -$97.6 million during Q2 2021, and its lowest value of -$197.5 million during Q4 2023.
  • Moreover, its 3-year median value for Operating Income was -$113.5 million (2023), whereas its average is -$120.4 million.
  • Its Operating Income has fluctuated over the past 5 years, first plummeted by 208.96% in 2021, then surged by 36.22% in 2024.
  • Over the past 5 years, Guardant Health's Operating Income (Quarterly) stood at -$98.2 million in 2021, then slumped by 48.79% to -$146.1 million in 2022, then slumped by 35.17% to -$197.5 million in 2023, then surged by 36.22% to -$126.0 million in 2024, then grew by 15.63% to -$99.0 million in 2025.
  • Its Operating Income was -$99.0 million in Q3 2025, compared to -$106.4 million in Q2 2025 and -$111.0 million in Q1 2025.